Transactivation of bad by vorinostat-induced acetylated p53 enhances doxorubicin-induced cytotoxicity in cervical cancer cells
Vorinostat (VOR) has been reported to enhance the cytotoxic effects of doxorubicin (DOX) with fewer side effects because of the lower DOX dosage in breast cancer cells. In this study, we investigated the novel mechanism underlying the synergistic cytotoxic effects of VOR and DOX co-treatment in cerv...
Saved in:
Published in | Experimental & molecular medicine pp. 1 - 8 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
생화학분자생물학회
01.02.2014
|
Subjects | |
Online Access | Get full text |
ISSN | 1226-3613 2092-6413 |
Cover
Loading…